Akebia Therapeutics, Inc. - Common Stock (AKBA)
CUSIP: 00972D105
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 263,222,327
- Total 13F shares
- 56,272,261
- Share change
- -785,431
- Total reported value
- $57,424,732
- Put/Call ratio
- 44%
- Price per share
- $1.02
- Number of holders
- 100
- Value change
- -$2,482,254
- Number of buys
- 51
- Number of sells
- 53
Quarterly Holders Quick Answers
What is CUSIP 00972D105?
CUSIP 00972D105 identifies AKBA - Akebia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00972D105:
Top shareholders of AKBA - Akebia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Alerce Investment Management, L.P. |
13F
|
Company |
5%
|
13,205,119
|
$24,165,368 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.1%
|
8,225,972
|
$15,053,529 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
2%
|
5,309,755
|
$9,715,000 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.4%
|
3,652,100
|
$6,683,000 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.2%
|
3,266,000
|
$5,976,780 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.96%
|
2,539,225
|
$4,646,782 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.86%
|
2,262,676
|
$4,140,697 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
1,818,947
|
$3,329,461 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.67%
|
1,762,414
|
$3,225,217 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.62%
|
1,637,578
|
$2,996,768 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.54%
|
1,413,653
|
$2,586,985 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.4%
|
1,044,471
|
$1,911,382 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.39%
|
1,023,275
|
$1,872,593 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.33%
|
866,554
|
$1,585,794 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.3%
|
790,483
|
$1,446,584 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.3%
|
788,375
|
$1,442,727 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.25%
|
650,350
|
$1,190,141 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.19%
|
503,244
|
$920,937 | — | 31 Mar 2024 | |
| Ellen Snow |
3/4/5
|
SVP, CFO and Treasurer |
—
mixed-class rows
|
743,300
mixed-class rows
|
$872,424 | — | 31 Jan 2024 | |
| Michel Dahan |
3/4/5
|
SVP, Chief Operating Officer |
—
mixed-class rows
|
896,092
mixed-class rows
|
$846,836 | — | 13 May 2024 | |
| Nicole R. Hadas |
3/4/5
|
SVP, Chief Legal Officer |
—
mixed-class rows
|
875,243
mixed-class rows
|
$820,566 | — | 13 May 2024 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.16%
|
428,549
|
$784,245 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.15%
|
398,247
|
$728,792 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.15%
|
398,060
|
$728,450 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.14%
|
355,456
|
$650,485 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
334,173
|
$611,537 | — | 31 Mar 2024 | |
| David A. Spellman |
3/4/5
|
SVP, CFO and Treasurer |
—
class O/S missing
|
446,483
|
$546,004 | — | 16 May 2023 | |
| Marathon Trading Investment Management LLC |
13F
|
Company |
0.1%
|
260,001
|
$475,802 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.1%
|
254,664
|
$466,035 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
210,000
|
$384,300 | — | 31 Mar 2024 | |
| SAPIENT CAPITAL LLC |
13F
|
Company |
0.08%
|
200,000
|
$366,000 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.07%
|
187,825
|
$343,720 | — | 31 Mar 2024 | |
| Point72 Asia (Singapore) Pte. Ltd. |
13F
|
Company |
0.07%
|
186,232
|
$340,805 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.07%
|
178,793
|
$327,191 | — | 31 Mar 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.07%
|
175,802
|
$321,717 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.06%
|
159,949
|
$292,707 | — | 31 Mar 2024 | |
| Violetta Cotreau |
3/4/5
|
SVP, Chief Accounting Officer |
—
class O/S missing
|
219,954
|
$268,982 | — | 12 May 2022 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.05%
|
142,274
|
$260,361 | — | 31 Mar 2024 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.05%
|
140,925
|
$257,893 | — | 31 Mar 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.05%
|
137,742
|
$252,000 | — | 31 Mar 2024 | |
| Dell J. Faulkingham |
3/4/5
|
SVP, CCO |
—
mixed-class rows
|
373,841
mixed-class rows
|
$212,590 | — | 28 Feb 2022 | |
| Creative Planning |
13F
|
Company |
0.04%
|
110,690
|
$202,563 | — | 31 Mar 2024 | |
| Orchard Capital Management, LLC |
13F
|
Company |
0.04%
|
108,460
|
$198,482 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
99,338
|
$181,789 | — | 31 Mar 2024 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.04%
|
92,554
|
$169,373 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
83,234
|
$152,318 | — | 31 Mar 2024 | |
| Brevan Howard Capital Management LP |
13F
|
Company |
0.03%
|
81,676
|
$149,467 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.03%
|
79,804
|
$146,041 | — | 31 Mar 2024 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.03%
|
77,000
|
$140,910 | — | 31 Mar 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.03%
|
73,350
|
$135,000 | — | 31 Mar 2024 |
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q2 2024
As of 30 Jun 2024,
Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,272,261 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Alerce Investment Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, JACOBS LEVY EQUITY MANAGEMENT, INC, Qube Research & Technologies Ltd, and Connor, Clark & Lunn Investment Management Ltd..
This page lists
100
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
108
Q2 2024 holders
100
Holder diff
-8
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.